Accordingly, we conducted dose-response analyses for a) lung cancer (ICD-9 162); b) upper aerodigestive tract cancers encompassing the naso-oropharyngeal regions, esophagus, and stomach (ICD-9 140-151); c) hemato- and lymphopoietic cancers (ICD-9 200-208, excluding chronic lymphatic leukemias); d) urinary-tract cancers (ICD-9 188-189); and e) prostate cancer (ICD-9 185).
In dose-response analyses, monotonic associations were observed between cumulative internal dose and mortality from hemato- and lymphopoietic cancers and from cancers of the upper aerodigestive tract (Tables 4 and 5).
68 Hematopoietic and Lymphopoietic cancers (a) Internal (ICD-9 200-208) radiation dose n=10 (per 10 mSv) RR p 0-year lag 1.
c] All causes of death 1,934 109(*) All malignant neoplasm 423 100 Respiratory system cancer 151 106 Central nervous system cancer - - Breast cancer 2 311 Thyroid cancer - - Leukemia 19 115 All other lymphopoietic
cancer 18 100 Nonmalignant respiratory disease 156 110 All heart disease 817 116(*) All external causes 156 109 Total mortality White females (n = 15,707(b) Cause of death Obs [SMR.